Search

Your search keyword '"Gluud, Maria"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Gluud, Maria" Remove constraint Author: "Gluud, Maria" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
154 results on '"Gluud, Maria"'

Search Results

1. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome

2. Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma

3. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma

4. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

5. RUNX2 as a novel biomarker for early identification of patients progressing to advanced-stage mycosis fungoides.

6. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma

9. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma

10. SATB1 in Malignant T Cells

11. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome

12. miRNA Signature in Early-stage Mycosis Fungoides

13. miRNA Signature in Early-stage Mycosis Fungoides

14. miRNA signature in early-stage mycosis fungoides

15. Inhibition of succinate dehydrogenase activity impairs human T cell activation and function:[Publisher correction]

16. JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)

17. The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma

18. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells

19. Low SATB1 Expression Promotes IL-5 and IL-9 Expression in Sézary Syndrome

20. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas

21. Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma

22. MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides

23. Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

24. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis

25. JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)

27. The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma

28. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas

29. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells

30. Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

31. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

32. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma

33. Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma

34. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis

35. Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

36. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma

37. Antibiotics inhibit tumor and disease activity in cutaneous T cell lymphoma

38. Single-cell heterogeneity in Sézary syndrome

39. SATB1 in malignant T cells

40. Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma.

41. Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma.

42. Single-cell heterogeneity in Sézary syndrome

43. STAT5 induces miR-21 expression in cutaneous T cell lymphoma

44. Keratinocytes present Staphylococcus aureusenterotoxins and promote malignant and non-malignant T cell proliferation in cutaneous T cell lymphoma

45. Staphylococcus aureusinduces drug resistance in cancer T cells in Sézary syndrome

46. STAT5 induces miR-21 expression in cutaneous T cell lymphoma

47. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureusand Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma

48. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma

49. Staphylococcus Aureus Induces Stat5 Dependent Mir-155 Expression In Cutaneous T-Cell Lymphoma (Ctcl)

50. Staphylococcus aureusalpha-toxin inhibits CD8+T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma

Catalog

Books, media, physical & digital resources